Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram vs. Sertraline in Dysthymic Disorder
NCT00234312Phase 4Completed
- Sponsor
- Oregon Health & Science University
- Start
- Sep 2005
- Primary completion
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of escitalopram in persistent depressive disorder (PDD) (2 arms), sponsored by Oregon Health & Science University. Primary endpoint: Hamilton Depression Rating Scale (17 items). Started Sep 2005; status: completed.
02
Drugs
escitalopram
03
Conditions
persistent depressive disorder (PDD)
Beyond the preview
Go deeper on NCT00234312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00234312.